Live Breaking News & Updates on India Exclusive

Stay updated with breaking news from India exclusive. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Новини світу: коронавірусне пекло - що відбувається в Індії - Ексклюзив ТСН

Новини світу: коронавірусне пекло - що відбувається в Індії - Ексклюзив ТСН
tsn.ua - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tsn.ua Daily Mail and Mail on Sunday newspapers.

Sa Indian Institute , India Exclusive , Indian Institute , இந்தியா பிரத்தியேக , இந்தியன் நிறுவனம் ,

EXCLUSIVE-Ford puts projects with Mahindra on hold as it reassesses India strategy -sources


Ford, Mahindra had plans to build SUVs, share powertrains
Ford renegotiating all projects with Mahindra - sources
NEW DELHI/DETROIT, Feb 18 (Reuters) - Ford Motor has frozen all projects it was working on with Mahindra & Mahindra while it finalises a new India strategy, three people familiar with the U.S. carmaker’s plans told Reuters, weeks after the two companies called off their planned joint venture.
“The options could include working out a new relationship with Mahindra or ending the relationship and related vehicles completely,” one of the sources said.
The two other sources said they expect Ford to make a decision in about a month on whether to proceed with Mahindra in a different form or not, adding Ford Chief Executive Jim Farley wants to see a path to greater profitability in India. ....

New Delhi , Aditi Shah , Kapil Sharma , Dianne Craig , Ben Klayman , Euan Rocha , Jim Farley , Susan Fenton , Suzuki Motor Corp , Ford Motor , Ford Chief Executive Jim Farley , Michigan Based Ford , Hyundai Motor , Ford India , India Exclusive , Asia Pacific , Company News , Emerging Market Countries , North America , Major News , Picture Available , South Asia , United States , புதியது டெல்ஹி , கபில் ஷர்மா , டயான் கிரேக் ,

EXCLUSIVE-India's Serum to sell AstraZeneca vaccine to Bangladesh at $4/dose - sources


Ruma Paul, Krishna N. Das
2 分钟阅读
DHAKA/NEW DELHI, Jan 11 (Reuters) - Serum Institute of India will sell the AstraZeneca coronavirus vaccine to Bangladesh at $4 a dose, three sources with knowledge of the mater told Reuters, about 47% more than India will pay for its inoculation campaign.
The pricing for Bangladesh, the world’s eighth-most populous country, provides a first glimpse of what it will cost other low- and middle-income countries that are seeking to secure the vaccine developed by British drugmaker AstraZeneca with Oxford University.
Bangladesh, a country of more than 160 million people, in November signed a preliminary agreement to buy 30 million doses of the shot from Serum - the world’s biggest vaccine maker by volume. ....

United Kingdom , Krishnan Das , Nick Macfie , Ruma Paul , Gates Foundation , Oxford University , Serum Institute Of India , Health Coronavirus Bangladesh , India Exclusive , Asia Pacific , Corporate Events , Company News , Corona Virus , Diplomacy Foreign Policy , Emerging Market Countries , General News , General Health , Health Medicine , Healthcare Trbc Level 1 , Human Diseases Conditions , Infectious Diseases , South America Central , Major News , Pharmaceuticals Trbc Level 4 , Pharmaceuticals Trbc Level 3 , Pharmaceuticals Nec Trbc Level 5 ,